Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
2.
JNCI Cancer Spectr ; 5(2)2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33733052

RESUMEN

Background: European studies reported an increased risk of nonmelanoma skin cancer associated with hydrochlorothiazide (HCTZ)-containing products. We examined the risks of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) associated with HCTZ compared with angiotensin-converting enzyme inhibitors (ACEIs) in a US population. Methods: We conducted a retrospective cohort study in the US Food and Drug Administration's Sentinel System. From the date of HCTZ or ACEI dispensing, patients were followed until a SCC or BCC diagnosis requiring excision or topical chemotherapy treatment on or within 30 days after the diagnosis date or a censoring event. Using Cox proportional hazards regression models, we estimated the hazard ratios (HRs), overall and separately by age, sex, and race. We also examined site- and age-adjusted incidence rate ratios (IRRs) by cumulative HCTZ dose within the matched cohort. Results: Among 5.2 million propensity-score matched HCTZ and ACEI users, the incidence rate (per 1000 person-years) of BCC was 2.78 and 2.82, respectively, and 1.66 and 1.60 for SCC. Overall, there was no difference in risk between HCTZ and ACEIs for BCC (HR = 0.99, 95% confidence interval [CI] = 0.97 to 1.00), but there was an increased risk for SCC (HR = 1.04, 95% CI = 1.02 to 1.06). HCTZ use was associated with higher risks of BCC (HR = 1.09, 95% CI = 1.07 to 1.11) and SCC (HR = 1.15, 95% CI = 1.12 to 1.17) among Caucasians. Cumulative HCTZ dose of 50 000 mg or more was associated with an increased risk of SCC in the overall population (IRR = 1.19, 95% CI = 1.05 to 1.35) and among Caucasians (IRR = 1.27, 95% CI = 1.10 to 1.47). Conclusions: Among Caucasians, we identified small increased risks of BCC and SCC with HCTZ compared with ACEI. Appropriate risk mitigation strategies should be taken while using HCTZ.


Asunto(s)
Antihipertensivos/efectos adversos , Carcinoma Basocelular/inducido químicamente , Carcinoma de Células Escamosas/inducido químicamente , Hidroclorotiazida/efectos adversos , Fármacos Fotosensibilizantes/efectos adversos , Neoplasias Cutáneas/inducido químicamente , Adulto , Factores de Edad , Anciano , Inhibidores de la Enzima Convertidora de Angiotensina/administración & dosificación , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Antihipertensivos/administración & dosificación , Carcinoma Basocelular/epidemiología , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/etnología , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Hidroclorotiazida/administración & dosificación , Incidencia , Masculino , Persona de Mediana Edad , Fármacos Fotosensibilizantes/administración & dosificación , Puntaje de Propensión , Modelos de Riesgos Proporcionales , Grupos Raciales/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales , Neoplasias Cutáneas/epidemiología , Neoplasias Cutáneas/etnología , Rayos Ultravioleta , Estados Unidos/epidemiología , Estados Unidos/etnología , Población Blanca
3.
BMJ Case Rep ; 13(12)2020 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-33318269

RESUMEN

Acrokeratosis paraneoplastica (Bazex syndrome) is a rare paraneoplastic skin condition characterised by acral psoriasiform plaques, with a predilection for the nose, ears, hands and feet. It typically presents before the discovery of an internal malignancy and is often misdiagnosed as an inflammatory dermatitis that does not respond to treatment. It is associated with squamous cell carcinoma of the aerodigestive tract and lung, as well as adenocarcinoma of the lung, colon and gastrum. Here, we describe the second reported case of Bazex syndrome in the setting of pancreatic adenocarcinoma and the first such case in a patient of African ancestry.


Asunto(s)
Adenocarcinoma/diagnóstico , Carcinoma Basocelular/etiología , Hipotricosis/etiología , Neoplasias Pancreáticas/diagnóstico , Neoplasias Cutáneas/etiología , Adenocarcinoma/etnología , Negro o Afroamericano , Anciano , Carcinoma Basocelular/etnología , Diagnóstico Diferencial , Humanos , Hipotricosis/etnología , Masculino , Neoplasias Pancreáticas/etnología , Neoplasias Cutáneas/etnología
4.
Photodermatol Photoimmunol Photomed ; 36(1): 53-57, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31386220

RESUMEN

BACKGROUND: Hispanics are one of the fastest growing populations in the United States. Few studies have characterized the patterns of keratinocyte carcinoma presentation in Hispanics. OBJECTIVE: The study aimed to compare the clinical and histologic characteristics of keratinocyte carcinomas in Hispanics and non-Hispanic whites. MATERIALS AND METHODS: A five-year retrospective chart review was conducted at a single academic center to identify all histologically-confirmed cases of keratinocyte carcinomas. Tumor characteristics were then compared between Hispanics and non-Hispanic whites. RESULTS: A total of 197 tumors were identified of which 76% occurred in non-Hispanic whites and 24% in Hispanics. Tumor diameter was not larger and histologic subtype was not more aggressive in Hispanics compared to non-Hispanic whites. Age of diagnosis of basal cell carcinoma was younger among Hispanics compared to non-Hispanic whites (P < .05). CONCLUSION: Hispanics were not more likely to present with more high-risk keratinocyte carcinomas compared to non-Hispanic whites in terms of tumor diameter, differentiation and subtype.


Asunto(s)
Carcinoma Basocelular , Hispánicos o Latinos , Queratinocitos/patología , Neoplasias Cutáneas , Población Blanca , Anciano , Anciano de 80 o más Años , Carcinoma Basocelular/epidemiología , Carcinoma Basocelular/etnología , Carcinoma Basocelular/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Neoplasias Cutáneas/epidemiología , Neoplasias Cutáneas/etnología , Neoplasias Cutáneas/patología
6.
Dermatol Clin ; 37(4): 519-526, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31466591

RESUMEN

Skin cancers are relatively rare in patients with skin of color; however, they are an important public health concern because of disparities in patient outcomes. Gaps in skin cancer knowledge exist because of lack of large-scale studies involving people of color, and limitations in data collection methods and skin classification paradigms. Additional research is needed to address questions regarding risk and reasons for disparate skin cancer outcomes in these patients. We summarize the clinical and epidemiologic features for basal cell carcinoma, squamous cell carcinoma, and melanoma and touch on some of their unique features in patients with skin of color.


Asunto(s)
Asiático , Negro o Afroamericano , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Hispánicos o Latinos , Melanoma/etnología , Neoplasias Cutáneas/etnología , Pigmentación de la Piel , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/patología , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patología , Errores Diagnósticos , Detección Precoz del Cáncer , Disparidades en Atención de Salud/etnología , Humanos , Melanoma/diagnóstico , Melanoma/patología , Infecciones por Papillomavirus/epidemiología , Factores de Riesgo , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología
7.
Singapore Med J ; 60(9): 479-482, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30773599

RESUMEN

We retrospectively reviewed the clinical features, management and outcomes of patients diagnosed with basal cell carcinoma (BCC) of the vulva at the Gynaecological Cancer Centre, KK Women's and Children's Hospital, Singapore, between 1 January 2000 and 28 February 2014. Patients with vulvar BCC were identified from the cancer registry, and their medical records reviewed and analysed. A total of 11 patients with vulvar BCC were identified. Mean age at diagnosis was 63 (range 30-85) years. Ethnically, ten patients were Chinese and one was Malay. Average time from onset of symptoms to diagnosis was 13.8 (range 2-60) months. The most common presenting symptoms were lump and pruritus. All patients were managed surgically. Recurrence was noted in only one patient. Vulvar BCC, although rare, has an excellent prognosis when managed appropriately. Histological diagnosis of all persistent papules, plaques and pigmented lesions is important for early diagnosis.


Asunto(s)
Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/terapia , Neoplasias de la Vulva/diagnóstico , Neoplasias de la Vulva/terapia , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Carcinoma Basocelular/etnología , Femenino , Humanos , Persona de Mediana Edad , Pronóstico , Prurito/complicaciones , Sistema de Registros , Estudios Retrospectivos , Singapur/epidemiología , Centros de Atención Terciaria , Resultado del Tratamiento , Neoplasias de la Vulva/etnología
8.
J Am Acad Dermatol ; 81(2): 373-378, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30703457

RESUMEN

BACKGROUND: Because most of the US population will consist of nonwhite individuals by the year 2043, it is essential that both physicians and patients are educated about skin cancer in nonwhite persons. OBJECTIVE: To update the epidemiology, investigate specific risk factors, and facilitate earlier diagnosis and intervention of keratinocyte carcinoma in nonwhite individuals. METHODS: Institutional review board-approved retrospective chart review of all nonwhite patients who had received a biopsy-proven diagnosis of skin cancer at Drexel Dermatology during June 2008-June 2015. RESULTS: Squamous cell carcinoma (SCC) was the most commonly diagnosed skin cancer in black and Asian populations, and basal cell carcinoma was the most common skin cancer in Hispanics. Black persons exhibited the majority of their SCC lesions in sun-protected areas, particularly the anogenital area. On average, current smokers received skin cancer diagnoses 12.27 years earlier than former smokers and 9.36 years earlier than nonsmokers. LIMITATIONS: Single-center design and interpractitioner variability of skin examination. CONCLUSION: The importance of lesions in photoprotected areas in nonwhite individuals should not go overlooked. However, emphasis should also be placed on active examination of sun-protected areas in nonwhite persons and recognition of the relationship between human papillomavirus and genital SCC lesions. Smoking cessation should be integrated in dermatologic counseling of all patients. Interventions tailored to each of these ethnic groups are needed.


Asunto(s)
Asiático/estadística & datos numéricos , Negro o Afroamericano/estadística & datos numéricos , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Hispánicos o Latinos/estadística & datos numéricos , Neoplasias Cutáneas/etnología , Edad de Inicio , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hipertensión/epidemiología , Huésped Inmunocomprometido , Queratinocitos/patología , Persona de Mediana Edad , Philadelphia/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Fumar/epidemiología
9.
Dermatol Surg ; 45(5): 660-665, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30614839

RESUMEN

BACKGROUND: Basal cell carcinoma (BCC) is an uncommon diagnosis in African Americans, and as a result, there is a limited amount of data available. OBJECTIVE: We sought to describe the clinical characteristics of BCC in African Americans treated with Mohs micrographic surgery (MMS). METHODS: We performed a retrospective case series in an ambulatory referral center at a single academic institution from 2007 to 2017 to characterize BCCs in African Americans treated with MMS. RESULTS: A total of 17 patients, who identified as black or African American, with 18 BCCs were included for analysis. Patients were predominantly female (82%) with a mean age at diagnosis of 61 years. Seventy-eight percent of tumors were located in the head and neck region with 50% of BCCs located in high-risk areas. The average preoperative and postoperative defect size was 1.78 and 5.90 cm, respectively, with a mean number of 2.2 Mohs stages required for tumor clearance. One patient had Gorlin syndrome. CONCLUSION: The presented retrospective review adds to limited available reported studies regarding BCC in African Americans to potentially aid in early recognition of these tumors.


Asunto(s)
Carcinoma Basocelular/etnología , Neoplasias de Cabeza y Cuello/etnología , Neoplasias Cutáneas/etnología , Negro o Afroamericano , Carcinoma Basocelular/cirugía , Femenino , Neoplasias de Cabeza y Cuello/cirugía , Humanos , Masculino , Persona de Mediana Edad , Cirugía de Mohs , Estudios Retrospectivos , Neoplasias Cutáneas/cirugía , Resultado del Tratamiento
12.
Dermatol Surg ; 44(7): 903-910, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29746428

RESUMEN

BACKGROUND: Skin cancer has traditionally been studied in Caucasian skin. Although it does occur with increased relative frequency in Caucasians, patients with skin of color suffer from elevated morbidity and mortality when diagnosed with skin cancer. OBJECTIVE: To detail the unique demographic and clinical features of nonmelanoma skin cancer (NMSC) in patients with skin of color, including Hispanic, African American, and Asian patients. MATERIALS AND METHODS: A complete PubMed search was conducted spanning dates from 1947 to June 2017 yielding a total of 185 manuscripts, from which 45 were included in this review. RESULTS: Relative to Caucasians, NMSC, comprised squamous cell carcinoma and basal cell carcinoma, has unique demographic and clinical features in African Americans, Hispanics, and Asians. CONCLUSION: Familiarization with these unique presentations of skin cancer in skin of color is imperative to accurate identification and treatment of cutaneous malignancies in these populations and ultimately to improved disease-related outcomes.


Asunto(s)
Pueblo Asiatico , Negro o Afroamericano , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Hispánicos o Latinos , Neoplasias Cutáneas/etnología , Carcinoma Basocelular/patología , Carcinoma de Células Escamosas/patología , Humanos , Neoplasias Cutáneas/patología
13.
JAMA Dermatol ; 154(3): 323-329, 2018 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-29387873

RESUMEN

Importance: Squamous cell carcinoma (SCC) is the most common skin cancer diagnosed in solid organ transplant recipients (OTRs) and confers significant mortality. The development of SCC in the genital region is elevated in nonwhite OTRs. Viral induction, specifically human papillomavirus (HPV), is hypothesized to play a role in the pathophysiology of these lesions. Objective: To assess the prevalence and types of genital lesions observed in OTRs. Design, Setting, and Participants: This retrospective review included 496 OTRs who underwent full skin examination from November 1, 2011, to April 28, 2017, at an academic referral center. The review was divided into 2 distinct periods before a change in clinical management that took effect on February 1, 2016 (era 1) and after that change (era 2). Patient awareness of genital lesions was assessed. All lesions clinically suggestive of malignant tumors were biopsied and underwent HPV polymerase chain reaction typing. Main Outcomes and Measures: Number and types of genital lesions, proportion of malignant tumors positive for HPV, and patients cognizant of genital lesions. Results: Of the total 496 OTRs, 376 OTRs were evaluated during era 1 (mean [SD] age, 60 years; age range, 32-94 years; 45 [65.2%] male; 164 [43.6%] white) and 120 OTRs were evaluated during era 2 of the study (mean age, 56 years; age range, 22-79 years; 76 [63.3%] male; 30 [25.0%] white). Overall, 111 of the 120 OTRs (92.5%) denied the presence of genital lesions during the history-taking portion of the medical examination. Genital lesions were found in 53 OTRs (44.2%), cutaneous malignant tumors (basal cell carcinoma and SCC in situ) in 6 (5.0%), genital SCC in situ in 3 (4.2%), and condyloma in 29 (24.2%). Eight of the 12 SCC in situ lesions (66.7%) were positive for high-risk HPV. Seven tested positive for HPV-16 and HPV-18, and 1 tested positive for high-risk HPV DNA but could not be further specified. Conclusions and Relevance: Genital lesions in OTRs are common, but awareness is low. All OTRs should undergo thorough inspection of genital skin as a part of routine posttransplant skin examinations. Patients with darker skin types are disproportionately affected by cutaneous genital malignant tumors and should undergo a targeted program of early detection, prevention, and awareness focused on the risk of genital skin cancer after transplant. High-risk HPV subtypes are associated with genital SCC in OTRs. Additional studies are warranted to identify significant risk factors for HPV infection and to assess the utility of pretransplant HPV vaccination in the prevention of cutaneous genital malignant tumors.


Asunto(s)
Carcinoma in Situ/epidemiología , Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Condiloma Acuminado/epidemiología , Neoplasias de los Genitales Femeninos/epidemiología , Neoplasias de los Genitales Masculinos/epidemiología , Trasplante de Órganos/estadística & datos numéricos , Neoplasias Cutáneas/epidemiología , Adulto , Negro o Afroamericano , Anciano , Anciano de 80 o más Años , Asiático , Carcinoma in Situ/etnología , Carcinoma in Situ/virología , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Condiloma Acuminado/etnología , Femenino , Neoplasias de los Genitales Femeninos/etnología , Neoplasias de los Genitales Femeninos/virología , Neoplasias de los Genitales Masculinos/etnología , Neoplasias de los Genitales Masculinos/virología , Conocimientos, Actitudes y Práctica en Salud , Hispánicos o Latinos , Papillomavirus Humano 16 , Papillomavirus Humano 18 , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Papillomavirus/diagnóstico , Infecciones por Papillomavirus/virología , Philadelphia/epidemiología , Prevalencia , Estudios Retrospectivos , Neoplasias Cutáneas/etnología , Población Blanca , Adulto Joven
15.
Dermatol Surg ; 42(5): 639-45, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27100961

RESUMEN

BACKGROUND: Nonmelanoma skin cancers (NMSCs) are the most common malignancy in the United States. Although historically most cases occurred in whites, in recent years, NMSC incidence in Hispanics and Asians has increased. As Hispanics and Asians are the 2 fastest growing groups in the United States, the NMSC rise in these populations is concerning. Currently, data on clinical characteristics of NMSCs in these minorities are limited, and a thorough analysis of risk differences among Hispanic, Asian, and white patients is lacking. OBJECTIVE: To assess differences in NMSC prevalence, risk factors, and clinical presentation among Hispanic, Asian, and white populations at University of California San Diego Dermatologic and Mohs Micrographic Surgery Center. METHODS: Five-year retrospective chart review. RESULTS: Of 4,029 NMSC cases, 3,881 (96.3%) were in whites, 115 (2.9%) were in Hispanics, and 33 (0.8%) were in Asians. Most cases in whites occurred in men, whereas this gender ratio was reversed for Hispanics and Asians. Hispanics had significantly more cases occurring in the "central face." CONCLUSION: The rise of NMSCs in Hispanic and Asians, especially among women, is concerning given that they are the fastest growing ethnic populations in the United States. It is important that proper counseling for photoprotection be stressed to these populations.


Asunto(s)
Asiático/estadística & datos numéricos , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Hispánicos o Latinos/estadística & datos numéricos , Neoplasias Cutáneas/etnología , Población Blanca/estadística & datos numéricos , Anciano , Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Neoplasias Cutáneas/epidemiología , Estados Unidos/epidemiología
16.
JAMA Dermatol ; 151(9): 976-81, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26039887

RESUMEN

IMPORTANCE: The incidence of basal cell carcinomas (BCCs) is increasing globally, but incidence rates in the United States are difficult to quantify because BCCs are not reportable tumors. OBJECTIVE: To estimate annual BCC incidence rates by age, sex, and race/ethnicity to identify demographically distinct high-risk subgroups and to assess changes in rates over time. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study (January 1, 1998, through December 31, 2012), we studied 147 093 patients with BCC from Kaiser Permanente Northern California, a large, integrated health care provision system, identified using a previously validated BCC registry. MAIN OUTCOMES AND MEASURES: We estimated annual BCC incidence rates by age, sex, and race/ethnicity and assessed changes in rates over time. The BCC incidence rates were standardized to the age, sex, and race/ethnicity distribution of the 2010 US Census population. RESULTS: In models adjusting for age, sex, and race, male patients had higher rates than female patients (incidence rate ratio [IRR], 1.65; 95% CI, 1.60-1.70). Persons 65 through 79 years of age and those 80 years and older had higher rates than persons 40 through 64 years of age (IRR, 2.96; 95% CI, 2.86-3.06; and IRR, 5.14; 95% CI, 4.94-5.35, respectively). Whites had higher rates than multiracial persons (IRR, 1.96; 95% CI, 1.80-2.13), Hispanics (IRR, 8.56; 95% CI, 7.79-9.41), Asians (IRR, 33.13; 95% CI, 27.84-39.42), and blacks (IRR, 72.98; 95% CI, 49.21-108.22). CONCLUSIONS AND RELEVANCE: We estimate that BCCs occur in approximately 2 million Americans annually. Our findings provide an updated estimate of the incidence of BCCs, highlight the changing epidemiologic findings, and better identify demographically distinct high-risk subgroups.


Asunto(s)
Carcinoma Basocelular/etnología , Etnicidad , Sistema de Registros , Medición de Riesgo/métodos , Neoplasias Cutáneas/etnología , Adolescente , Adulto , Distribución por Edad , Factores de Edad , Anciano , Anciano de 80 o más Años , California/epidemiología , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Distribución por Sexo , Factores Sexuales , Adulto Joven
17.
Exp Dermatol ; 24(6): 476-8, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25809071

RESUMEN

Melanocortin 1 receptor (MC1R) gene variants are a major contributor to pigmentation characteristics and the modulation of sporadic basal cell carcinoma (BCC) risk. This is a hospital-based, case-control study to investigate the association of MC1R variants and pigmentary characteristics with the risk of BCC development in a Southern European population in Greece. In total, 141 patients with BCC and 166 controls were studied. Increased BCC risk was found for the presence of 2 or more MC1R variants (OR:3.07, 95% CI:1.13-8.34), or 2 or more variants of which at least 1 was major function (OR:7.15, 95% CI:1.37-5.52), after adjustment for the 'red hair colour' (RHC) phenotype. Increased BCC risk persisted in the presence of 2 or more MC1R variants (OR:4.15, 95% CI:1.35-12.72), after adjustment for potential confounding factors including skin color (P:0.237) and atypical nevi (OR:9.57, 95% CI:2.19-41.81, P:0.003). MC1R genotype is a risk factor for the development of BCC in Greek patients independently of pigmentary characteristics, and the combination of MC1R variants may modulate this risk.


Asunto(s)
Carcinoma Basocelular/genética , Variación Genética/genética , Pigmentación/genética , Receptor de Melanocortina Tipo 1/genética , Neoplasias Cutáneas/genética , Adulto , Anciano , Carcinoma Basocelular/etnología , Estudios de Casos y Controles , Femenino , Predisposición Genética a la Enfermedad/etnología , Predisposición Genética a la Enfermedad/genética , Genotipo , Grecia , Color del Cabello/genética , Humanos , Masculino , Persona de Mediana Edad , Fenotipo , Pigmentación/fisiología , Factores de Riesgo , Neoplasias Cutáneas/etnología
18.
Australas J Dermatol ; 56(3): 175-9, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25179179

RESUMEN

BACKGROUND/OBJECTIVES: Susceptibility to and clinical presentation of basal cell carcinoma (BCC) differ in Asian and Caucasian populations. This study aims to evaluate the epidemiological and clinicopathological characteristics of BCC in a multiracial Singaporean population, with a secondary comparative analysis between Chinese and Caucasian patients. METHODS: We prospectively studied patients with newly diagnosed, histologically confirmed BCC at the National Skin Centre, Singapore from 2004 to 2008. RESULTS: In total, 274 BCC from 260 patients were studied, with 19 patients having two or more tumours. Their mean age was 67.5 years and 54% were male. Chinese comprised 80% and Caucasians 14%. The Chinese were 1.8-fold as likely as Caucasians to be older than 60 years, and experienced itch thrice more frequently. Caucasians developed multiple BCC threefold and truncal or upper limb BCC 2.9-fold more frequently than the Chinese. In terms of tumour subtype, morphoeic BCC was 2.7-fold more common in Caucasians. Pigmented BCC occurred 2.7-fold more often in the Chinese, most frequently on the head and neck of elderly Chinese. CONCLUSIONS: Compared to the Chinese, BCC occurred more often in younger Caucasians, with a predilection for the trunk and upper limb, suggesting a greater role for recreational sun exposure as a risk factor. Pigmented BCC more commonly occurred on the head and neck of elderly Chinese and may be reflective of cumulative sun exposure as a risk factor. Aggressive morphoeic BCC was more common in Caucasians than in Singaporean Chinese patients.


Asunto(s)
Carcinoma Basocelular/etnología , Neoplasias Primarias Múltiples/etnología , Singapur/epidemiología , Neoplasias Cutáneas/etnología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Basocelular/patología , China/etnología , Femenino , Cabeza , Humanos , Hiperpigmentación/etnología , Masculino , Persona de Mediana Edad , Cuello , Estudios Prospectivos , Prurito/etnología , Neoplasias Cutáneas/patología , Torso , Extremidad Superior , Población Blanca/etnología
19.
J Fr Ophtalmol ; 38(1): 41-5, 2015 Jan.
Artículo en Francés | MEDLINE | ID: mdl-25530349

RESUMEN

INTRODUCTION: In this work, the authors aim to study clinical and epidemiological characteristics of ocular and orbital primary cancers in sub-Saharan African. PATIENTS AND METHODS: This is a retrospective study over a period of 21 years, from 1984 to 2004, including all cases of ocular cancer, histologically proven after surgery of the globe or the orbit. For each patient, we studied the following parameters: age, sex, reason(s) for consultation, the affected eye, and histological result of the operative specimen. These data were collected by studying the departmental surgical registry, patient medical records and the tumor registry of the anatomicopathology laboratory of a tertiary care hospital in sub-Saharan Africa. RESULTS: We collected data on 111 black patients, among whom 15 cases (13.5%) presented with bilateral involvement, for a total of 126 eyes. The sex ratio was 1.17. Presenting signs showed a predominance of leukocoria (30.2%) followed by proptosis (21.7%) and in third place, protruding conjunctival mass (10.8%). Retinoblastoma was found most frequently, representing 66.6% of the oculo-orbital tumors and 95.45% of the tumors of the globe; followed by epidermoid carcinoma, representing 15.08% of cases. Malignant melanoma was third most common, representing 4.76%, with 83% arising in the anterior uvea and 7% in the choroid. Basal cell carcinoma and rhabdomyosarcoma follow in fourth place. Basal cell carcinoma constituted half (50%) of the eyelid tumors. Rhabdomyosarcoma was the most common orbital tumor in our series (57%). Next were lymphomas with conjunctival localization (2.38%), acute leukemia with orbital localization (1.59%) and rare tumors, palpebral dermatofibrosarcoma (0.79%), an orbital angiosarcoma (0.79%), a glioblastoma of the globe (0.79%) and a malignant solitary fibrous tumor of the orbit (0.79%). CONCLUSION: Ocular and orbital primary cancers in blacks remain tumors of the young, equally distributed between the sexes. Retinoblastoma is the most frequent, followed by epidermoid carcinoma. The globe is the preferential localization of these cancers.


Asunto(s)
Población Negra , Neoplasias del Ojo/etnología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Niño , Preescolar , Neoplasias de la Conjuntiva/etnología , Neoplasias del Ojo/patología , Neoplasias de los Párpados/etnología , Neoplasias de los Párpados/patología , Femenino , Neoplasias Hematológicas/etnología , Humanos , Lactante , Recién Nacido , Masculino , Melanoma/etnología , Persona de Mediana Edad , Neoplasias Primarias Múltiples/etnología , Retinoblastoma/etnología , Estudios Retrospectivos , Rabdomiosarcoma/etnología , Senegal , Adulto Joven
20.
Australas J Dermatol ; 55(3): 176-84, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25117159

RESUMEN

The burden of non-infectious skin disease in the Indigenous Australian population has not been previously examined. This study considers the published data on the epidemiology and clinical features of a number of non-infectious skin diseases in Indigenous Australians. It also outlines hypotheses for the possible differences in the prevalence of such diseases in this group compared with the general Australian population. There is a paucity of literature on the topic but, from the material available, Indigenous Australians appear to have a reduced prevalence of psoriasis, type 1 hypersensitivity reactions and skin cancer but increased rates of lupus erythematosus, kava dermopathy and vitamin D deficiency when compared to the non-Indigenous Australian population. This article profiles the prevalence and presentation of non-infectious skin diseases in the Indigenous Australian population to synthesise our limited knowledge and highlight deficiencies in our understanding.


Asunto(s)
Nativos de Hawái y Otras Islas del Pacífico , Enfermedades de la Piel/etnología , Australia/epidemiología , Australia/etnología , Carcinoma Basocelular/etnología , Carcinoma de Células Escamosas/etnología , Eccema/etnología , Humanos , Hipersensibilidad Inmediata/etnología , Incidencia , Kava/efectos adversos , Lupus Eritematoso Discoide/etnología , Lupus Eritematoso Sistémico/etnología , Melanoma/etnología , Prevalencia , Psoriasis/etnología , Psoriasis/genética , Enfermedades de la Piel/epidemiología , Neoplasias Cutáneas/etnología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA